CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
Lab to promote collaborative ventures between Belmont's School of Pharmacy
and health care providers
NASHVILLE, Tenn., July 1 /PRNewswire/ -- Cumberland Emerging
Technologies, Inc. (CET) today announced that Belmont University has
established the Belmont School of Pharmacy Department of Pharmaceutical
Sciences Laboratory at the CET Life Sciences Center. The Life Sciences
Center, which is located in downtown Nashville, provides lab and office
space, equipment and infrastructure to early-stage biopharmaceutical
ventures.
(Photo: http://www.newscom.com/cgi-bin/prnh/20080701/CLTU108 )
Belmont has leased the space to support research and service programs
of its School of Pharmacy. The primary objective of the lab is to provide
dosage form development, characterization and quality analysis. The school
will work with the pharmaceutical industry and local and regional health
care providers to meet previously unmet and emerging needs related to drug
delivery.
The work being performed at the Life Sciences Center is designed to
help provide drug delivery solutions, which is unique to pharmacy practice
and which, until now, has not played a major role in middle Tennessee's
robust health care scene," said Dr. Andrew Webster, Chair and Professor of
Pharmaceutical Sciences at Belmont's School of Pharmacy. "By partnering
with CET, our faculty and students have access to a community of resources
to advance research that will help drug developers bring their products to
patients who need them most."
"We are delighted to welcome Belmont School of Pharmacy to our growing
roster of tenants at the Life Sciences Center," said A.J. Kazimi, Chief
Executive Officer of Cumberland Pharmaceuticals and CET. "Partnering with
outstanding academic research and training programs like this one is a key
component of CET's strategy, and we look forward to providing laboratory
and equipment infrastructure to support their promising research."
Belmont's School of Pharmacy announced last week that it has received
approval from The Accreditation Council for Pharmacy Education (ACPE) to
seat its first class of 75 students for the 2008-09 academic year.
Belmont University, host of the 2008 Town Hall Presidential Debate, is
a fast-growing community of nearly 4,800 students who come from almost
every state and more than 25 countries. Committed to being a leader among
teaching universities, Belmont brings together the best of liberal arts and
professional education in a Christian community of learning and service.
Belmont's purpose is to help students explore their passions and develop
their talents to meet the world's needs. With more than 75 areas of study,
12 master's programs and three doctoral degrees, there is no limit to the
ways Belmont University can expand an individual's horizon. For more
information, visit www.belmont.edu.
Cumberland Emerging Technologies, Inc. (www.cet-fund.com) is a joint
initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University
and the Tennessee Technology Development Corporation. The mission of CET is
to bring biomedical technologies and products conceived at Vanderbilt and
other regional research centers to the marketplace. CET helps manage the
development and commercialization process for select projects, and provides
expertise on intellectual property, regulatory, manufacturing and marketing
issues that are critical to successful new biomedical products. CET's Life
Sciences Center, located in Nashville, Tennessee, provides laboratory
space, equipment and infrastructure to early-stage life sciences companies.
SOURCE Cumberland Emerging Technologies, Inc.
Featured Video
Journalists and Bloggers
![]()
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.




